James · Journal of cardiovascular pharmacology 1992 · double-blind crossover trial · n=14

Blood pressure lowering and cerebral blood flow: a comparison of the effects of carvedilol and propranolol on the cerebral circulation in hypertensive patients.

Level 2 - randomized trial

Double-blind crossover trial in human subjects

PubMed 1378148 · record verified 2026-08-26

What was done

Following a review of blood pressure autoregulation and cerebral blood flow mechanisms in hypertension, researchers conducted a double-blind, crossover trial in 14 patients with mild-to-moderate hypertension to compare the effects of carvedilol and propranolol on blood pressure reduction and cerebral circulation.

What was found

The abstract reports no numerical values. Carvedilol showed no effect on cerebral blood flow, while propranolol was associated with a slight tendency toward reduced cerebral blood flow. This difference did not reach statistical significance.

Why it matters

The study suggests that different antihypertensive agents with equivalent blood pressure-lowering capabilities may exert distinct effects on cerebral perfusion, with carvedilol potentially preserving cerebral blood flow.

Limits

The clinical trial component had a very small sample size (n = 14) and was underpowered, failing to achieve statistical significance. Quantitative measurements, baseline values, dosages, and exact duration of crossover treatments were omitted in the abstract.

Cited by